Document is current
Any future updates will be listed below
-
Authors
Yanagisawa, Takafumi https://orcid.org/0000-0002-7410-0712
Miki, Jun
Matsukawa, Akihiro
Iwatani, Kosuke
Sato, Shun
Hayashida, Yasushi
Okada, Yohei
Shimoda, Masayuki
Takahashi, Hiroyuki
Shariat, Shahrokh F.
Kimura, Takahiro
- License Information
-
More Information
Article History
Received: 14 February 2023
Accepted: 14 February 2023
First Online: 12 March 2023
Disclosures
: Takahiro Kimura is a paid consultant/advisor of Astellas, Bayer, Janssen and Sanofi. Shahrokh F. Shariat received honoraria from Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, and Takeda. Shahrokh F. Shariat also has a consulting or advisory role with Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, and Takeda, as well as being part of the speakers bureau for Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, and Takeda. The other authors declare no conflicts of interest associated with this manuscript.
